{"corpus_id":205251311,"paper_sha":"3c29b0feb39b4a56405edf40bdc1283a488d8093","doi":"10.1016/j.ijfoodmicro.2011.05.025","arxiv_id":null,"pmid":21742394,"pmcid":null,"mag_id":2051115786,"dblp_id":null,"acl_id":null,"title":"Production of bioactive substances by intestinal bacteria as a basis for explaining probiotic mechanisms: bacteriocins and conjugated linoleic acid.","year":2012,"publication_date":"2012-01-16","venue":"Journal of food microbiology","journal":{"name":"International journal of food microbiology","pages":"\n          189-205\n        ","volume":"152 3"},"journal_issn":null,"journal_title":null,"publication_types":["JournalArticle"],"pubmed_pub_types":["Journal Article","Research Support, Non-U.S. Gov't"],"s2_fields_of_study":["Biology","Medicine"],"reference_count":266,"citation_count":283,"influential_citation_count":2,"is_open_access":true,"arxiv_categories":null,"arxiv_license":null,"arxiv_journal_ref":null,"mesh_headings":[{"d":"Animals","mj":false,"ui":"D000818"},{"d":"Bacteriocins","mj":false,"qs":[{"q":"metabolism","mj":true,"ui":"Q000378"}],"ui":"D001430"},{"d":"Bifidobacterium","mj":false,"qs":[{"q":"metabolism","mj":true,"ui":"Q000378"}],"ui":"D001644"},{"d":"Fatty Acids","mj":false,"qs":[{"q":"metabolism","mj":false,"ui":"Q000378"}],"ui":"D005227"},{"d":"Gastrointestinal Tract","mj":false,"qs":[{"q":"microbiology","mj":true,"ui":"Q000382"}],"ui":"D041981"},{"d":"Humans","mj":false,"ui":"D006801"},{"d":"Lactobacillus","mj":false,"qs":[{"q":"metabolism","mj":true,"ui":"Q000378"}],"ui":"D007778"},{"d":"Linoleic Acids, Conjugated","mj":false,"qs":[{"q":"metabolism","mj":true,"ui":"Q000378"}],"ui":"D044243"},{"d":"Mice","mj":false,"ui":"D051379"},{"d":"Mice, Inbred BALB C","mj":false,"ui":"D008807"},{"d":"Probiotics","mj":false,"qs":[{"q":"metabolism","mj":true,"ui":"Q000378"}],"ui":"D019936"}],"chemicals":[{"n":"Bacteriocins","ui":"D001430","reg":"0"},{"n":"Fatty Acids","ui":"D005227","reg":"0"},{"n":"Linoleic Acids, Conjugated","ui":"D044243","reg":"0"}],"comments_corrections":null,"source_flags":5,"s2_open_access_pdf_url":"https://t-stor.teagasc.ie/bitstream/11019/85/1/O%27Shea%20et%20al%20%20Review%202012%20post%20print%20with%20Notice.pdf","s2_open_access_landing_url":"https://www.semanticscholar.org/paper/3c29b0feb39b4a56405edf40bdc1283a488d8093","s2_open_access_license":"CCBYNCSA","s2_open_access_status":"GREEN","pmc_open_access_pdf_url":null,"pmc_open_access_landing_url":null,"pmc_open_access_license":null,"pmc_open_access_status":null,"unpaywall_open_access_pdf_url":null,"unpaywall_open_access_landing_url":null,"unpaywall_open_access_license":null,"unpaywall_open_access_status":null,"abstract":"The mechanisms by which intestinal bacteria achieve their associated health benefits can be complex and multifaceted. In this respect, the diverse microbial composition of the human gastrointestinal tract (GIT) provides an almost unlimited potential source of bioactive substances (pharmabiotics) which can directly or indirectly affect human health. Bacteriocins and fatty acids are just two examples of pharmabiotic substances which may contribute to probiotic functionality within the mammalian GIT. Bacteriocin production is believed to confer producing strains with a competitive advantage within complex microbial environments as a consequence of their associated antimicrobial activity. This has the potential to enable the establishment and prevalence of producing strains as well as directly inhibiting pathogens within the GIT. Consequently, these antimicrobial peptides and the associated intestinal producing strains may be exploited to beneficially influence microbial populations. Intestinal bacteria are also known to produce a diverse array of health-promoting fatty acids. Indeed, certain strains of intestinal bifidobacteria have been shown to produce conjugated linoleic acid (CLA), a fatty acid which has been associated with a variety of systemic health-promoting effects. Recently, the ability to modulate the fatty acid composition of the liver and adipose tissue of the host upon oral administration of CLA-producing bifidobacteria and lactobacilli was demonstrated in a murine model. Importantly, this implies a potential therapeutic role for probiotics in the treatment of certain metabolic and immunoinflammatory disorders. Such examples serve to highlight the potential contribution of pharmabiotic production to probiotic functionality in relation to human health maintenance.","claims":[{"public_id":"cl_4301f1ffed5604ea370858734a73ddd7","status":"active","text":"Bacteriocin production can give producing strains a competitive advantage in complex microbial environments through antimicrobial activity, helping them establish and persist while directly inhibiting pathogens in the gastrointestinal tract.","confidence":0.92,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_4301f1ffed5604ea370858734a73ddd7"},{"public_id":"cl_303e327c22561e0882719256557e34fc","status":"active","text":"Certain intestinal bifidobacteria produce conjugated linoleic acid, and oral administration of conjugated linoleic acid-producing bifidobacteria and lactobacilli modulates liver and adipose tissue fatty-acid composition in a murine model.","confidence":0.95,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_303e327c22561e0882719256557e34fc"},{"public_id":"cl_edce164002490ac7206103c4fc1d0596","status":"active","text":"Pharmabiotic production contributes to probiotic functionality and suggests a potential therapeutic role for probiotics in certain metabolic and immunoinflammatory disorders.","confidence":0.83,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_edce164002490ac7206103c4fc1d0596"}],"concepts":[{"public_id":"co_19b80edc8148e4c69bb32cbb53a6859b","status":"active","name":"gastrointestinal tract","description":"The digestive tract that hosts complex intestinal microbial communities.","types":["anatomical structure"],"aliases":["GIT"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_19b80edc8148e4c69bb32cbb53a6859b"},{"public_id":"co_2fa6e31ef025fb94bdb4ad388b03e223","status":"active","name":"probiotic functionality","description":"The capacity of probiotics to confer health benefits in the host.","types":["biological function"],"aliases":["probiotic mechanisms"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_2fa6e31ef025fb94bdb4ad388b03e223"},{"public_id":"co_593706d678a3b6b3534bba60dd25b835","status":"active","name":"competitive advantage","description":"A fitness benefit that helps bacteriocin-producing strains outcompete other microbes in a shared environment.","types":["effect"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_593706d678a3b6b3534bba60dd25b835"},{"public_id":"co_5ce0dc4f5f21dde6a399dcaf4fb1136e","status":"active","name":"pharmabiotics","description":"Bioactive substances produced by microorganisms that can directly or indirectly affect human health.","types":["bioactive substance"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_5ce0dc4f5f21dde6a399dcaf4fb1136e"},{"public_id":"co_72dbf01c6236d73180cac46e44b49fd8","status":"active","name":"conjugated linoleic acid","description":"A fatty acid produced by some intestinal bacteria and associated with health-promoting effects.","types":["fatty acid","pharmabiotic substance"],"aliases":["CLA"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_72dbf01c6236d73180cac46e44b49fd8"},{"public_id":"co_800a992cf3afb565faf5f2451cef6950","status":"active","name":"murine model","description":"An experimental mouse model used to test the effects of oral administration of probiotic strains.","types":["animal model","experimental model"],"aliases":["mouse model"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_800a992cf3afb565faf5f2451cef6950"},{"public_id":"co_87e12bafd1d74d637b914e7d10f1a334","status":"active","name":"bacteriocin production","description":"The synthesis of bacteriocins by intestinal bacteria.","types":["biological process","pharmabiotic substance"],"aliases":["bacteriocins"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_87e12bafd1d74d637b914e7d10f1a334"},{"public_id":"co_f2b2423484fd788e17254d34b30b828c","status":"active","name":"intestinal bifidobacteria","description":"Bifidobacterial strains in the intestine that can produce conjugated linoleic acid.","types":["bacterial group"],"aliases":["bifidobacteria"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_f2b2423484fd788e17254d34b30b828c"},{"public_id":"co_f64dd7ad40a1bc93cf97dcd8c58f466b","status":"active","name":"metabolic and immunoinflammatory disorders","description":"A set of disorders involving metabolism and immune-inflammatory processes that may be targets of probiotic therapy.","types":["disease category"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_f64dd7ad40a1bc93cf97dcd8c58f466b"}],"external_ids":{"DOI":"10.1016/j.ijfoodmicro.2011.05.025","ArXiv":null,"PubMed":21742394,"PubMedCentral":null,"MAG":2051115786,"DBLP":null,"ACL":null},"open_access":{"is_open_access":true,"pdf_url":"https://t-stor.teagasc.ie/bitstream/11019/85/1/O%27Shea%20et%20al%20%20Review%202012%20post%20print%20with%20Notice.pdf","landing_url":"https://www.semanticscholar.org/paper/3c29b0feb39b4a56405edf40bdc1283a488d8093","source":"semantic_scholar","pdf_url_source":"semantic_scholar_open_access_pdf","license":"CCBYNCSA","status":"GREEN","reason":null},"reference_availability":{"status":"available","references_indexed":true,"full_text_available":false,"full_text_source":null,"count_basis":"semantic_scholar_metadata","extraction_status":"not_applicable","reason":null},"source":{"provider":"episteme2","base_corpus":"semantic_scholar_dump","freshness_mode":"unknown","basis":["semantic_scholar_metadata","postgres_metadata"],"limits":["paper metadata is based on indexed upstream scholarly datasets","claims and concepts are available only for extracted papers","absence of claims or concepts means no extracted graph data is available in this response"],"status":"available","degraded":false,"degraded_reasons":[],"diagnostics":{"status":"available","degraded":false,"degraded_reasons":[],"metadata_status":"available","graph_status":"available","abstract_status":"available"},"source_flags":5},"paper_id":630699,"paper_uid":"5084062e-21a8-4db8-a404-a1408cf0ee32","canonical_identity":{"paper_id":630699,"paper_uid":"5084062e-21a8-4db8-a404-a1408cf0ee32","identity_status":"available","lookup_basis":"semantic_scholar_external_id","compatibility_path":"corpus_id"},"url":"https://sah.borca.ai/papers/205251311"}